tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market
HPHA
Heidelberg Pharma AG
RESEARCH TOOLSreports
Want to see DE:HPHA full AI Analyst Report?

Heidelberg Pharma AG (HPHA) Ratios

5 Followers

Heidelberg Pharma AG Ratios

DE:HPHA's free cash flow for Q2 2026 was €0.91. For the 2026 fiscal year, DE:HPHA's free cash flow was decreased by € and operating cash flow was €0.30. See a summary of the company’s cash flow.
Ratios
TTM
Feb 26Feb 25Feb 24Feb 23
Liquidity Ratios
Current Ratio
 5.29 2.53 5.95 2.86 3.15
Quick Ratio
 3.83 1.58 4.47 2.33 2.98
Cash Ratio
 3.48 1.34 3.68 2.20 2.91
Solvency Ratio
 -0.50 -0.80 -0.62 -0.93 -0.56
Operating Cash Flow Ratio
 -3.46 -2.82 -3.70 -1.70 -0.32
Short-Term Operating Cash Flow Coverage
 0.00 -310.49 -256.29 -5.96 -0.56
Net Current Asset Value
€ -23.28M€ -20.72M€ 17.71M€ 35.62M€ 53.94M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.03 0.36 0.08 0.16
Debt-to-Equity Ratio
 >-0.01 -0.11 0.71 0.12 0.24
Debt-to-Capital Ratio
 >-0.01 -0.12 0.42 0.11 0.19
Long-Term Debt-to-Capital Ratio
 0.00 -0.11 0.00 0.00 0.00
Financial Leverage Ratio
 -3.30 -3.49 1.97 1.43 1.51
Debt Service Coverage Ratio
 -10.22K -428.12 -71.49 -2.92 -1.09
Interest Coverage Ratio
 -10.72K -9.66K -173.56 -27.85 -21.83
Debt to Market Cap
 0.00 <0.01 <0.01 0.04 0.07
Interest Debt Per Share
 <0.01 0.03 0.47 0.14 0.45
Net Debt to EBITDA
 0.80 0.31 0.41 2.01 4.04
Profitability Margins
Gross Profit Margin
85.90%-81.41%61.29%67.01%74.73%
EBIT Margin
-450.15%-3255.36%-280.91%-198.65%-91.53%
EBITDA Margin
-416.37%-3062.01%-268.19%-189.74%-87.45%
Operating Profit Margin
-457.60%-3255.36%-358.55%-215.13%-99.03%
Pretax Profit Margin
-424.80%-2829.08%-282.98%-206.38%-96.07%
Net Profit Margin
-444.62%-2901.15%-282.98%-206.38%-106.42%
Continuous Operations Profit Margin
-444.62%-2901.15%-282.98%-206.38%-106.42%
Net Income Per EBT
104.66%102.55%100.00%100.00%110.77%
EBT Per EBIT
92.83%86.91%78.92%95.93%97.01%
Return on Assets (ROA)
-70.59%-110.87%-31.92%-28.92%-19.59%
Return on Equity (ROE)
444.89%387.26%-62.79%-41.24%-29.56%
Return on Capital Employed (ROCE)
-85.74%-176.20%-46.58%-41.93%-25.24%
Return on Invested Capital (ROIC)
-85.74%-175.53%-46.38%-37.65%-20.71%
Return on Tangible Assets
-86.90%-144.27%-37.37%-33.11%-21.50%
Earnings Yield
-27.97%-31.46%-17.33%-15.82%-9.25%
Efficiency Ratios
Receivables Turnover
 3.47 0.62 1.15 6.67 12.75
Payables Turnover
 0.24 0.37 0.32 0.41 1.70
Inventory Turnover
 0.10 0.25 0.15 0.31 1.02
Fixed Asset Turnover
 38.03 1.60 1.96 2.56 4.94
Asset Turnover
 0.16 0.04 0.11 0.14 0.18
Working Capital Turnover Ratio
 0.34 0.05 0.18 0.20 0.69
Cash Conversion Cycle
 2.17K 1.06K 1.60K 347.84 171.26
Days of Sales Outstanding
 105.23 587.66 317.24 54.68 28.63
Days of Inventory Outstanding
 3.62K 1.46K 2.42K 1.18K 357.64
Days of Payables Outstanding
 1.55K 989.04 1.14K 883.68 215.02
Operating Cycle
 3.73K 2.05K 2.74K 1.23K 386.28
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.53 -0.68 -0.63 -0.72 -0.24
Free Cash Flow Per Share
 -0.53 -0.68 -0.64 -0.74 -0.25
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.02 1.03 1.07
Dividend Paid and CapEx Coverage Ratio
 -394.33 -245.62 -64.88 -35.08 -14.46
Capital Expenditure Coverage Ratio
 -394.33 -245.62 -64.88 -35.08 -14.46
Operating Cash Flow Coverage Ratio
 -539.32 -27.13 -1.35 -5.77 -0.55
Operating Cash Flow to Sales Ratio
 -3.33 -21.68 -4.32 -3.42 -0.48
Free Cash Flow Yield
-21.01%-23.61%-26.86%-26.93%-4.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.61 -3.16 -5.77 -6.32 -10.81
Price-to-Sales (P/S) Ratio
 15.90 92.22 16.33 13.04 11.50
Price-to-Book (P/B) Ratio
 -8.32 -12.31 3.62 2.61 3.20
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.76 -4.24 -3.72 -3.71 -22.47
Price-to-Operating Cash Flow Ratio
 -4.77 -4.25 -3.78 -3.82 -24.03
Price-to-Earnings Growth (PEG) Ratio
 0.06 -0.03 1.27 0.37 0.31
Price-to-Fair Value
 -8.32 -12.31 3.62 2.61 3.20
Enterprise Value Multiple
 -3.02 -2.70 -5.68 -4.86 -9.12
Enterprise Value
 93.48M 120.59M 104.40M 91.00M 147.64M
EV to EBITDA
 -3.02 -2.70 -5.68 -4.86 -9.12
EV to Sales
 12.56 82.75 15.24 9.23 7.97
EV to Free Cash Flow
 -3.76 -3.80 -3.48 -2.63 -15.58
EV to Operating Cash Flow
 -3.77 -3.82 -3.53 -2.70 -16.66
Tangible Book Value Per Share
 -0.49 -0.42 0.47 0.87 1.55
Shareholders’ Equity Per Share
 -0.30 -0.23 0.66 1.06 1.79
Tax and Other Ratios
Effective Tax Rate
 -0.05 -0.03 0.00 0.00 -0.11
Revenue Per Share
 0.16 0.03 0.15 0.21 0.50
Net Income Per Share
 -0.71 -0.91 -0.42 -0.44 -0.53
Tax Burden
 1.05 1.03 1.00 1.00 1.11
Interest Burden
 0.94 0.87 1.01 1.04 1.05
Research & Development to Revenue
 4.52 26.61 3.19 2.85 1.42
SG&A to Revenue
 0.93 5.22 1.19 0.53 0.26
Stock-Based Compensation to Revenue
 0.03 0.08 0.00 0.10 0.03
Income Quality
 0.75 0.75 1.53 1.65 0.45
Currency in EUR